Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1187295

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Hospitals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what contractual terms his Department has agreed with providers of private hospitals being used for NHS purposes during the covid-19 outbreak.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	33743
answer	answer is ministerial correction date of answer 21/04/2020 answer text <p>The Department and NHS England and NHS Improvement have worked with the independent sector to increase capacity and resource within the National Health Service, adding around 8,000 beds and 20,000 clinical staff. This will ensure that more facilities are available for patients diagnosed with COVID-19.</p><p>Under the agreement, the independent sector will be reimbursed at cost.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/04/2020 10:10:21 answering member 4362 label Biography information for Edward Argar
tabling member	4433 label Biography information for Thangam Debbonaire

1185481

registered interest
date	16/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure pharmacies do not run out of medical supplies as a result of the covid-19 outbreak.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	30141
answer	answer is ministerial correction date of answer 24/03/2020 answer text <p>The country is well prepared to deal with any impacts of COVID-19 and we have stockpiles of generic drugs in the event of any supply issues.</p><p>We are working closely with industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need. Precautions are in place to reduce the likelihood of future shortages.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/03/2020 15:40:14 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1182192

registered interest
date	03/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Calea: Parenteral Nutrition
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what monitoring his Department undertakes on the compliance of Calea UK Ltd with improvements agreed between the company and the Medical and Healthcare products Regulatory Authority in their provision of Total Parenteral Nutrition to NHS patients.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	24364
answer	answer is ministerial correction date of answer 11/03/2020 answer text <p>The Department is in regular dialogue with the Medicines and Healthcare products Regulatory Agency (MHRA) and they have advised it continues to work closely with the company to ensure that they make the necessary changes. The MHRA Inspectors have made on-site technical visits, carried out further inspections and its senior management has met with the company on a number of occasions to discuss the improvements which need to be implemented. The MHRA has recently advised that progress is being made and it is currently awaiting the results of a third-party audit, carried out on behalf of the company, which will independently assess the measures implemented to date. Once the MHRA has reviewed the outcome of this audit they anticipate carrying out further inspections to confirm that the company has implemented the necessary changes to bring their aseptic procedures into compliance.</p><p>In addition to Calea UK Ltd, there are four commercial operations authorised to provide Total Parenteral Nutrition (TPN) to the National Health Service. There are a number (approximately 40) of NHS units also authorised by the MHRA for manufacture and supply of TPNs across the NHS.</p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 24366 question first answered 11/03/2020 16:21:32 answering member 4527 label Biography information for Helen Whately
tabling member	4433 label Biography information for Thangam Debbonaire

1182193

registered interest
date	03/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Calea: Parenteral Nutrition
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department used to approve Calea UK Ltd as the supplier of total parenteral nutrition to the NHS.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	24365
answer	answer is ministerial correction date of answer 10/03/2020 answer text <p>The criteria used to approve manufacturers is set out in the “guide to good manufacturing practices” and is monitored via inspection processes performed by the Medicines Healthcare Regulatory Authority (MHRA). If a company has met these standards, an “authorize to manufacture” is granted. If upon routine re-inspections, the manufacturing processes do not meet the acceptable standard, further actions are taken, as with the case of Calea UK Ltd.</p><p>NHS England and NHS Improvement’s Commercial Medicines Unit (CMU) is responsible for awarding framework agreements for England, in line with procurement regulations, for parenteral nutrition. All suppliers including Calea UK Ltd are required to provide available production capacity, satisfy quality, safety, finance and governance requirements and evidence that they hold a licence with the MHRA and meet its regulatory requirements.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/03/2020 14:18:05 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1182194

registered interest
date	03/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Calea: Parenteral Nutrition
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether Calea UK Ltd is the sole provider of total parenteral nutrition to the NHS.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	24366
answer	answer is ministerial correction date of answer 11/03/2020 answer text <p>The Department is in regular dialogue with the Medicines and Healthcare products Regulatory Agency (MHRA) and they have advised it continues to work closely with the company to ensure that they make the necessary changes. The MHRA Inspectors have made on-site technical visits, carried out further inspections and its senior management has met with the company on a number of occasions to discuss the improvements which need to be implemented. The MHRA has recently advised that progress is being made and it is currently awaiting the results of a third-party audit, carried out on behalf of the company, which will independently assess the measures implemented to date. Once the MHRA has reviewed the outcome of this audit they anticipate carrying out further inspections to confirm that the company has implemented the necessary changes to bring their aseptic procedures into compliance.</p><p>In addition to Calea UK Ltd, there are four commercial operations authorised to provide Total Parenteral Nutrition (TPN) to the National Health Service. There are a number (approximately 40) of NHS units also authorised by the MHRA for manufacture and supply of TPNs across the NHS.</p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 24364 question first answered 11/03/2020 16:21:32 answering member 4527 label Biography information for Helen Whately
tabling member	4433 label Biography information for Thangam Debbonaire

1175754

registered interest
date	03/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Migrants: Detainees
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Health and Social Care, how many people detained at an immigration detention centre were assessed for a mental illness in 2019.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	11655
answer	answer is ministerial correction date of answer 11/02/2020 answer text <p>The information is not available in the requested format.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 11/02/2020 14:13:55 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4433 label Biography information for Thangam Debbonaire

1171078

registered interest
date	15/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what level of funding his Department has made available for drug addiction treatment in (a) the UK (b) Bristol.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	3784
answer	answer is ministerial correction date of answer 22/01/2020 answer text <p>Spending on health care, including drug treatment services is a devolved matter. In England, local authorities are responsible for the commissioning and uptake of drug treatment services. They are funded to do so through the public health grant. In 2019-20, £3.1 billion has been provided for public health services, including drug treatment.</p><p> </p><p>Any death related to drug use is an avoidable tragedy. Heroin-related deaths are rising across the United Kingdom, including in Bristol. This increase is linked to an ageing group of older heroin users with multiple and complex needs and in increasingly poor health. Half of opiate-related deaths occur among those who have never – or have not for several years – been in drug treatment.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 3785 question first answered 22/01/2020 13:43:32 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1171079

registered interest
date	15/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heroin: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the trends in the level of heroin-related deaths in (a) the UK and (b) Bristol.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	3785
answer	answer is ministerial correction date of answer 22/01/2020 answer text <p>Spending on health care, including drug treatment services is a devolved matter. In England, local authorities are responsible for the commissioning and uptake of drug treatment services. They are funded to do so through the public health grant. In 2019-20, £3.1 billion has been provided for public health services, including drug treatment.</p><p> </p><p>Any death related to drug use is an avoidable tragedy. Heroin-related deaths are rising across the United Kingdom, including in Bristol. This increase is linked to an ageing group of older heroin users with multiple and complex needs and in increasingly poor health. Half of opiate-related deaths occur among those who have never – or have not for several years – been in drug treatment.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 3784 question first answered 22/01/2020 13:43:32 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1171080

registered interest
date	15/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of naloxone for preventing death caused by heroin overdose.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	3786
answer	answer is ministerial correction date of answer 22/01/2020 answer text <p>No assessment has been made on the adequacy of the availability of naloxone for preventing death caused by heroin overdose.</p><p>Local authorities are responsible for assessing local needs and commissioning drug prevention, treatment and harm reduction services to meet these needs. This includes making sure they have sufficient coverage of naloxone to prevent drug-related deaths.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/01/2020 14:17:19 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire

1156354

registered interest
date	25/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Public Health: Emergencies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria his Department uses to identify public health emergencies.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	5450
answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 16:49:11 answering member 4380 label Biography information for Jo Churchill
tabling member	4433 label Biography information for Thangam Debbonaire